Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6 thioguanine (NSC-752)

J. O. Armitage, C. P. Burns

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Twenty adults (median age, 58 yr) with acute nonlymphoblastic leukemia who had achieved complete remission were given maintenance therapy with monthly courses of cytosine arabinoside and 6 thioguanine, each in a dose of 100 mg/m2 every 12 hr for 10 doses. The toxicity was minimal with no severe infections, bleeding, or treatment related deaths. The treatment was often administered on an outpatient basis. The predicted life table median remission duration is 14 mth with 11 patients still in remission from 3+ to 29+ mth.

Original languageEnglish (US)
Pages (from-to)585-589
Number of pages5
JournalCANCER TREAT.REP.
Volume60
Issue number5
StatePublished - Dec 1 1976

Fingerprint

Thioguanine
Cytarabine
Acute Myeloid Leukemia
Maintenance
Life Tables
Outpatients
Therapeutics
Hemorrhage
Infection

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

@article{b6ca1a4b40ef4d98ab582df7411eac43,
title = "Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6 thioguanine (NSC-752)",
abstract = "Twenty adults (median age, 58 yr) with acute nonlymphoblastic leukemia who had achieved complete remission were given maintenance therapy with monthly courses of cytosine arabinoside and 6 thioguanine, each in a dose of 100 mg/m2 every 12 hr for 10 doses. The toxicity was minimal with no severe infections, bleeding, or treatment related deaths. The treatment was often administered on an outpatient basis. The predicted life table median remission duration is 14 mth with 11 patients still in remission from 3+ to 29+ mth.",
author = "Armitage, {J. O.} and Burns, {C. P.}",
year = "1976",
month = "12",
day = "1",
language = "English (US)",
volume = "60",
pages = "585--589",
journal = "Journal of the National Cancer Institute",
issn = "0027-8874",
publisher = "Oxford University Press",
number = "5",

}

TY - JOUR

T1 - Maintenance of remission in adult acute nonlymphoblastic leukemia using intermittent courses of cytosine arabinoside (NSC-63878) and 6 thioguanine (NSC-752)

AU - Armitage, J. O.

AU - Burns, C. P.

PY - 1976/12/1

Y1 - 1976/12/1

N2 - Twenty adults (median age, 58 yr) with acute nonlymphoblastic leukemia who had achieved complete remission were given maintenance therapy with monthly courses of cytosine arabinoside and 6 thioguanine, each in a dose of 100 mg/m2 every 12 hr for 10 doses. The toxicity was minimal with no severe infections, bleeding, or treatment related deaths. The treatment was often administered on an outpatient basis. The predicted life table median remission duration is 14 mth with 11 patients still in remission from 3+ to 29+ mth.

AB - Twenty adults (median age, 58 yr) with acute nonlymphoblastic leukemia who had achieved complete remission were given maintenance therapy with monthly courses of cytosine arabinoside and 6 thioguanine, each in a dose of 100 mg/m2 every 12 hr for 10 doses. The toxicity was minimal with no severe infections, bleeding, or treatment related deaths. The treatment was often administered on an outpatient basis. The predicted life table median remission duration is 14 mth with 11 patients still in remission from 3+ to 29+ mth.

UR - http://www.scopus.com/inward/record.url?scp=0017064988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017064988&partnerID=8YFLogxK

M3 - Article

C2 - 991147

AN - SCOPUS:0017064988

VL - 60

SP - 585

EP - 589

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 5

ER -